Startup

ST

Sereido Therapeutics

Biotech

Funding rounds in 2026

Grey amounts aren't counted in totals. † includes debt or other non-equity.

DateCompanyStageAmountInvestorsSector
5 Oct 2026 STSereido Therapeutics Series B 2nd Close ¥400M Shionogi & Co.Teikoku Ventures, Inc. BiotechDeep tech